These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 16772759

  • 21. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 22. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 23. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 Apr; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

  • 24. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 25. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A, Popov D, Dragan E, Dragomir E, Badila E.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):149-58. PubMed ID: 17612521
    [Abstract] [Full Text] [Related]

  • 26. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T, Heise T, Nosek L, Eckers U, Sawicki PT.
    J Hypertens; 2006 Jul 10; 24(7):1397-403. PubMed ID: 16794490
    [Abstract] [Full Text] [Related]

  • 27. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 10; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 28. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 29. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A, Feely J.
    Am J Hypertens; 2008 Jun 09; 21(6):663-7. PubMed ID: 18437130
    [Abstract] [Full Text] [Related]

  • 30. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 09; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H, Lewin A, Lukić T, Goodin T, Wei Chen.
    Ther Adv Cardiovasc Dis; 2010 Dec 09; 4(6):349-57. PubMed ID: 21088095
    [Abstract] [Full Text] [Related]

  • 32. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 09; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 33. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006 Jan 09; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
    Van Bortel LM, Fici F, Mascagni F.
    Am J Cardiovasc Drugs; 2008 Jan 09; 8(1):35-44. PubMed ID: 18303936
    [Abstract] [Full Text] [Related]

  • 35. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
    Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H.
    Asian J Androl; 2006 Mar 09; 8(2):177-82. PubMed ID: 16491268
    [Abstract] [Full Text] [Related]

  • 36. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 09; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 37. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan 09; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 38. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov 09; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 39. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O, Ertem B, Altun A.
    Anadolu Kardiyol Derg; 2011 Jun 09; 11(4):310-3. PubMed ID: 21543293
    [Abstract] [Full Text] [Related]

  • 40. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y, Arnott W.
    J Hum Hypertens; 1994 Apr 09; 8(4):283-8. PubMed ID: 8021909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.